Summary
Although the overall number of tuberculosis cases reported in developed countries has decreased markedly since about the middle of the twentieth century, at present active tuberculosis in the geriatric population is highly prevalent even in developed countries. With an increase in the aged population and striking progress in medicine during the past two decades, the development of tuberculosis infections and the active disease has been gradually changed; namely, the number of older people at risk of infection has been increasing. In the elderly, postprimary pulmonary tuberculosis and miliary tuberculosis are particularly difficult to diagnose. A high index of suspicion, a tuberculin skin test, and appropriate laboratory studies are essential for early diagnosis. In choosing the proper therapy for tuberculosis in the elderly, efficacy, patient compliance, and toxicity must be considered. During this decade, more so than ever before, much time and work will be required to more completely understand the factors that place a patient at risk for infection and to accomplish eradication of tuberculosis.
Similar content being viewed by others
References
Addington WW. The side effects and interactions of anti-tuberculosis drugs. Chest 76: 782–784, 1979
Alford RH. Antimycobacterial agents. In Mandell et al. (Eds) Principles and practice of infectious diseases, 3rd ed., pp. 350–360, Churchill Livingston Inc., New York, 1990
Alvarez S, Shell C, Berk ST. Pulmonary tuberculosis in elderly men. American Journal of Medicine 82: 602–606, 1987
American Thoracic Society. Treatment of tuberculosis in alcoholic patients. American Review of Respiratory Disease 116: 559–561, 1977
American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and child. American Review of Respiratory Disease 134: 355–363, 1986
Banyai AL. Pulmonary tuberculosis in the aged. American Review of Tuberculosis 21: 568–578, 1920
Battershill JH. Cutaneous testing in the elderly patient with tuberculosis. Chest 77: 188–189, 1980
Bobrowitz ID. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis. Lung 157: 117–125, 1980
Butterworth AE, David JR. Eosinophil function. New England Journal of Medicine 304: 154–156, 1981
Centers for Disease Control. Adverse drug reactions among children treated for tuberculosis. Morbidity and Mortality Weekly Report 29: 589–591, 1980
Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. American Review of Respiratory Disease 136: 570–574, 1987
Comstock GW. Epidemiology of tuberculosis. American Review of Respiratory Disease 125(3 Pt 2): 8–15, 1982
Comstock GW, Livesaf VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. American Journal of Epidemiology 99: 131–138, 1974
Dasta JF, Prior JA, Kurzrok S. Isoniazid-induced fever. Chest 75: 196–197, 1979
Davies BH. Infectivity of tuberculosis. Thorax 35: 481–482, 1980
Des Prez RM, Heim CR. Mycobacterium tuberculosis. In Mandell et al. (Eds) Principles and practice of infectious diseases, 3rd ed., pp 1877–1906, Churchill Livingstone Inc., New York, 1990
Dinarello CA, Wolff SM. Fever of unknown origin. In Mandell et al. (Eds) Principles and practice of infectious diseases, 3rd, ed., pp 468–479, 1990
Di Perri G, Cruciani M, Danzi MC, Luzzati R, De Checchi G, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 2: 1502–1504, 1989
Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest 92: 237–240, 1987
Editorial. World tuberculosis. Lancet 1: 689–691, 1965
Enarson DA, Grzybowski S. Incidence of active tuberculosis in the native population of Canada. Canadian Medical Association Journal 134: 1149–1152, 1986
Farer LS, Lowell LM, Meador MP. Extrapulmonary tuberculosis in the United States. American Journal of Epidemiology 109: 205–217, 1979
Fraser RG, Paré JAP, Paré PD, Fraser RS, Genereux GP (Eds). Diagnosis of diseases of the chest, 3rd ed., WS Saunders Company, Philadelphia, 1989
Freeman JT, Heiken CA. The geriatric aspect of pulmonary tuberculosis. American Journal of the Medical Sciences 202: 29–38, 1941
Girling DJ, Hitze KL. Adverse reactions of rifampicin. Bulletin of the World Health Organization 57: 45–49, 1979
Glassroth J, Robbins AG, Snider Jr DE. Tuberculosis in the 1980s. New England Journal of Medicine 302: 1441–1450, 1980
Goldman AL, Braman SS. Isoniazid: A review with emphasis on adverse effects. Chest 62: 71–77, 1972
Grzybowski S. Ontario studies on tuberculin sensitivity. Canadian Journal of Public Health 56: 181–192, 1965
Grzybowski S. The impact of treatment programs on the epidemiology of tuberculosis. Tubercle 66: 69–72, 1985
Grzybowski S, Allen EA. The challenge of tuberculosis in decline: a study based on the epidemiology of tuberculosis in Ontario, Canada. American Review of Respiratory Disease 90: 707–720, 1964
Hadlock FP, Park SK, Awe RJ. Rivera M. Unusual radiographic findings in adult pulmonary tuberculosis. American Journal of Roentgenology 134: 1015–1018, 1980
Hong Kong Tuberculosis Treatment Services/British Medical Research Council. Adverse reaction to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong. Tubercle 57: 81–95, 1976
Hopewell PC. Mycobacterial diseases. In Murray and Nadel (Eds) Textbook of respiratory medicine, pp. 856–915, WS Saunders Company, Philadelphia, 1988
Jacobson HG, Shapiro JH. Pulmonary tuberculosis. Radiologic Clinics of North America 1: 411–427, 1963
Johnston RN, Ritchie RT, Murray HF. Declining tuberculin sensitivity with advancing age. British Medical Journal 2: 720–724, 1963
Joress MH. Pulmonary tuberculosis in old people. New England Journal of Medicine 219: 885–887, 1938
Katz I, Rosenthal T, Michaeli D. Undiagnosed tuberculosis in hospitalized patients. Chest 87: 770–774, 1985
Khan MA, Kovnat DM, Bachus B, Whitcomb ME, Brody JS, et al. Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult. American Journal of Medicine 62: 31–38, 1977
Kopanoff DE, Snider Jr DE, Caras GJ. Isoniazid-related hepatitis. A US Public Health Service cooperative surveillance study. American Review of Respiratory Disease 117: 991–1001, 1978
Kurihara T, Aoki M. Surveillance of tuberculosis (in Japanese). Kekkaku 57: 613–635, 1982
Lester W. Rifampicin: a semisynthetic derivative of rifampicin — a prototype for the future. Annual Review of Microbiology 26: 85–102, 1972
Mahmoud AAF, Stone MK, Kellermeyer RW. Eosinophilopoietin: a circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. Journal of Clinical Investigation 60: 675–682, 1977
Mann J, Snider DE, Francis H, Quinn TC, Colebunders RL, et al. Association between HTLV-III/LAV infection and tuberculosis in Zaire. Journal of the American Medical Association 256: 346, 1986
McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a New York City Men’s Shelter Clinic (1982-1988). Chest 97: 798–805, 1990
Medical Research Council Tuberculosis and Chest Disease Unit. National survey of tuberculosis notifications in England and Wales 1978–9. British Medical Journal 281: 895–898, 1980
Medical Research Council Tuberculosis and Chest Disease Unit. National survey of notifications of tuberculosis in England and Wales in 1983. British Medical Journal 291: 658–661, 1985
Mitchell JR, Zimmerman HJ, Ishak KG. Thorgeirsson UP, Timbrell JA, et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Annals of Internal Medicine 84: 181–192, 1976
Nagami PH, Yoshikawa TT. Tuberculosis in the geriatric patient. Journal of the American Geriatrics Society 31: 356–363, 1983
National Consensus Conference on Tuberculosis. Standard therapy for tuberculosis 1985. Chest 87 (Suppl.): 117s–124s, 1985
Nichols GP. Diabetes among young tuberculosis patients: a review of the association of the two diseases. American Review of Tuberculosis and Pulmonary Diseases 76: 1016–1030, 1957
Patel KR. Pulmonary tuberculosis in residents of lodging houses, night shelters and common hostels in Glasgow: a 5-year prospective survey. British Journal of Diseases of the Chest 79: 60–66, 1985
Pitchenik AE, Cole C, Russell BW, Fischl MA, Spira TJ, et al. Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida. Annals of Internal Medicine 101: 641–645, 1984
Powell KE, Farer LS. The rising age of tuberculosis patients: a sign of success and failure. Journal of Infectious Disease 142: 946–948, 1980
Rahajoe NN, Rahajoe N, Boediman I, Said M, Lazuardi S. The treatment of tuberculosis meningitis in children with a combination of isoniazid, rifampicin and streptomycin. Preliminary report. Tubercle 60: 245–250, 1979
Sanders Jr WE. Rifampin. Annals of Internal Medicine 85: 82–86, 1976
Sarma GR, Immanuel C, Kailasam S, Narayana ASL, Venkatesan P. Rifampicin-induced release of hydrazine from isoniazid: a possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampicin. American Review of Respiratory Disease 133: 1072–1075, 1986
Segarra F, Sherman DS, Rodriguez-Aguero J. Lower lung field tuberculosis. American Review of Respiratory Disease 87: 37–46, 1963
Snider Jr DE, Salinas L, Kelly GD. Tuberculosis: an increasing problem among minorities in the United States. Public Health Reports 104: 646–657, 1989
Snider GL. Pulmonary tuberculosis and centrilobular emphysema. The ‘upright theory’ of apical localization. Archives of Internal Medicine 111: 762–771, 1963
Soejima R, Mikata A. Recent extrapulmonary tuberculosis (in Japanese). Kekkaku 60: 83–104, 1985
Stead WW. Undetected tuberculosis in prison: source of infection for community at large. Journal of the American Medical Association 240: 2544–2577, 1978
Stead WW. Tuberculosis among elderly persons: an outbreak in a nursing home. Annals of Internal Medicine 94: 606–610, 1981
Stead WW, Kerby GR, Schuleter DP, Jordahl CW. The clinical spectrum of primary tuberculosis in adults: confusion with reinfection in the pathogenesis of chronic tuberculosis. Annals of Internal Medicine 68: 731–744, 1968
Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. New England Journal of Medicine 312: 1483–1487, 1985
Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Annals of Internal Medicine 107: 837–842, 1987
Steiger Z, Nickel WO, Shannon GJ, Nedwicki EG, Higgins RF. Pulmonary tuberculosis after gastric resection. American Journal of Surgery 131: 668–671, 1976
Subcommittee of the Joint Tuberculosis Committee. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 45: 403–408, 1990
Sunahara S. Problems of hydrazine metabolism (in Japanese). Nippon Ishikai Zasshi 46: 322–333, 1961
Sunderam G, McDonald RJ, Maniatis T, Oleske J, Kapila R, et al. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). Journal of the American Medical Association 256: 362–366, 1986
Tuberculosis Clinical Conferences. Medical Journal of Australia 2: 176, 1977
Umeki S. Rifampicin and pulmonary fibrosis. Archives of Internal Medicine 148: 1663–1667, 1988
Umeki S. Comparison of younger and elderly patients with pulmonary tuberculosis. Respiration 55: 75–83, 1989a
Umeki S. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate. Japanese Journal of Medicine 28: 335–340, 1989b
Umeki S. Sequelae of pulmonary tuberculosis (in Japanese). Nippon Iji Shinpo 3445: 27–34, 1990
Umeki S, Hashiguchi K, Sumi M, Okimoto N, Yagi S, et al. Age-associated changes in clinical features of pulmonary tuberculosis (in Japanese). Abstract. 66th Annual Congress of the Japanese Society of Tuberculosis, Kyoto, April 23, 1991. Kekkaku 66: 270, 1991
Umeki S, Okimoto N, Soejima R, Hara Y. Investigation of severe tuberculous pneumonia associated with irreversible exacerbation after intensive antitubercular chemotherapy — with regard to the etiology of initial reversible roentgenographic progression. Kekkaku 64: 85–93, 1989
Umeki S, Shiojiri H, Nozawa Y. Chronic ethanol administration decreases fatty acyl-CoA desaturase activities in rat liver microsomes. FEBS Letters 169: 274–278, 1984
Umeki S, Sumi M, Niki Y, Soejima R. Concentrations of Superoxide dismutase and Superoxide anion in blood of patients with respiratory infections and compromised immune systems. Clinical Chemistry 33: 2230–2233, 1987
Van Scoy RE. Antituberculosis agents isoniazid, rifampicin, streptomycin, ethambutol. Mayo Clinic Proceedings 52: 694–700, 1977
Weaver RA. Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. American Review of Respiratory Disease 109: 162–165, 1974
Weinstein L. Chemotherapy of microbial diseases. In Goodman and Gilman (Eds) The pharmacological basis of therapeutics, 5th ed, pp. 1090–1224, Macmillan Co., 1975
Weller PF, Goetzl EJ. The human eosinophil. Roles in host defense and tissue injury. American Journal of Pathology 100: 793–820, 1980
Yoshikawa TT, Nagami PH. Adverse drug reactions in tuberculosis therapy: risks and recommendations. Geriatrics 37: 61–68, 1982
Zierski M, Bek E. Side-effects of drug regimens used in shortcourse chemotherapy for pulmonary tuberculosis: a controlled clinical study. Tubercle 61: 41–49, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Umeki, S. Age-Related Changes in the Manifestations of Tuberculosis. Drugs & Aging 1, 440–457 (1991). https://doi.org/10.2165/00002512-199101060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101060-00004